{"id":"thyroglobulin","rwe":[],"tags":[{"label":"Small Molecule","category":"modality"},{"label":"Active","category":"status"}],"phase":"marketed","safety":{},"trials":[],"aliases":[],"patents":[],"pricing":[],"_sources":{"trials":{"url":"https://clinicaltrials.gov/search?intr=THYROGLOBULIN","method":"api_direct","source":"ClinicalTrials.gov","rawText":"","confidence":1,"sourceType":"ctgov","retrievedAt":"2026-04-20T01:56:42.434117+00:00"},"regulatory.ca":{"url":"","method":"api_direct","source":"Health Canada DPD","rawText":"","confidence":1,"sourceType":"health_canada_dpd","retrievedAt":"2026-04-20T01:56:49.334989+00:00"},"publicationCount":{"url":"https://pubmed.ncbi.nlm.nih.gov/?term=THYROGLOBULIN","method":"api_direct","source":"PubMed/NCBI","rawText":"","confidence":1,"sourceType":"pubmed","retrievedAt":"2026-04-20T01:56:50.111088+00:00"},"crossReferences.chemblId":{"url":"https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL1201650/","method":"api_direct","source":"ChEMBL (EMBL-EBI)","rawText":"","confidence":1,"sourceType":"chembl","retrievedAt":"2026-04-20T01:56:50.576992+00:00"}},"allNames":["thyroglobulin"],"offLabel":[],"synonyms":[],"timeline":[],"approvals":[],"ecosystem":[],"mechanism":{"modality":"Small Molecule","explanation":"","oneSentence":"","technicalDetail":"Thyroglobulin is a dimeric protein composed of two identical subunits, each containing a thyroxine-binding site and a triiodothyronine-binding site. The protein undergoes iodination and coupling reactions to form the thyroid hormones T4 and T3, which are then released into the bloodstream."},"commercial":{},"references":[{"id":1,"url":"https://clinicaltrials.gov/search?intr=thyroglobulin","fields":["trials"],"source":"ClinicalTrials.gov"},{"id":2,"url":"https://pubmed.ncbi.nlm.nih.gov/?term=thyroglobulin","fields":["publications"],"source":"PubMed/NCBI"}],"_enrichedAt":"2026-03-31T10:34:52.757916","_validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:56:52.451932+00:00","fieldsConflicting":1,"overallConfidence":0.8},"biosimilars":[],"competitors":[],"genericName":"thyroglobulin","indications":{"approved":[],"offLabel":[],"pipeline":[]},"drugCategory":"active","labelChanges":[],"relatedDrugs":[],"trialDetails":[{"nctId":"NCT07453290","phase":"","title":"Dysregulation of the Soluble α-Klotho-FGF23 Axis in Hashimoto's Thyroiditis: A Case-Control Study","status":"NOT_YET_RECRUITING","sponsor":"Sehit Prof. Dr. Ilhan Varank Sancaktepe Training and Research Hospital","startDate":"2026-03-02","conditions":["Autoimmune Thyroiditis"],"enrollment":150,"completionDate":"2026-05-20"},{"nctId":"NCT07453225","phase":"PHASE1,PHASE2","title":"Empirical Radioactive Iodine Therapy in DTC","status":"NOT_YET_RECRUITING","sponsor":"Assiut University","startDate":"2026-04-01","conditions":["Differentiated Thyroid Cancer"],"enrollment":100,"completionDate":"2028-07-01"},{"nctId":"NCT06235814","phase":"NA","title":"Molecular Analysis for Precision Surgery in Thyroid Cancer Trial","status":"COMPLETED","sponsor":"University of California, Los Angeles","startDate":"2024-02-19","conditions":["Papillary Thyroid Cancer"],"enrollment":2,"completionDate":"2026-01-30"},{"nctId":"NCT04872439","phase":"","title":"Novel Antineuronal Antibodies in Gastrointestinal Motility Disorders","status":"ACTIVE_NOT_RECRUITING","sponsor":"Johns Hopkins University","startDate":"2021-04-22","conditions":["Autoimmune Gastrointestinal Dysmotility"],"enrollment":300,"completionDate":"2026-12-31"},{"nctId":"NCT04624477","phase":"","title":"Active Surveillance and Surgery Outcomes in Low Risk Papillary Thyroid Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2021-02-03","conditions":["Papillary Thyroid Cancer","Papillary Thyroid Carcinoma","Papillary Microcarcinoma of the Thyroid"],"enrollment":450,"completionDate":"2034-12-31"},{"nctId":"NCT03271892","phase":"","title":"Deciding on Active Surveillance or Surgery for Primary Management of Low Risk Papillary Thyroid Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2016-05-11","conditions":["Thyroid Cancer Stage I"],"enrollment":200,"completionDate":"2031-12-31"},{"nctId":"NCT05293366","phase":"","title":"LOng COvid COmorbidities: Endocrine,Metabolic,Neuropsychiatric,Muscle,Cardiovascular,Pulmonary,Dermatologic Dysfunctions","status":"RECRUITING","sponsor":"Federico II University","startDate":"2022-01-27","conditions":["Long Covid-19"],"enrollment":100,"completionDate":"2027-01-27"},{"nctId":"NCT07062211","phase":"","title":"Diagnostic Accuracy of Fluorodeoxyglucose-18 PET in the Evaluation of RPTC With Patient's Raised Thyroglobulin Level","status":"ACTIVE_NOT_RECRUITING","sponsor":"Superior University","startDate":"2025-03-17","conditions":["Papillary Thyroid Carcinoma"],"enrollment":39,"completionDate":"2026-03-01"},{"nctId":"NCT07056218","phase":"","title":"Outcome of RAI131 Therapy in Patients With Differentiated Thyroid Cancer (Low and Intermediate Risk)","status":"NOT_YET_RECRUITING","sponsor":"Sohag University","startDate":"2025-07-15","conditions":["Thyroid Cancer"],"enrollment":50,"completionDate":"2026-12-15"},{"nctId":"NCT05463107","phase":"","title":"Correlation Between Various Urinary Exosomal Protein Biomarkers and Pathological Manifestation in Thyroid Follicular Neoplasm: Early and Pre-operative Diagnosis of Follicular Thyroid Cancer","status":"RECRUITING","sponsor":"National Taiwan University Hospital","startDate":"2022-08-01","conditions":["Thyroid Cancer","Follicular Thyroid Cancer"],"enrollment":50,"completionDate":"2028-07-31"},{"nctId":"NCT02145143","phase":"EARLY_PHASE1","title":"Enhancing Radioiodine (RAI) Incorporation Into BRAF Mutant, RAI-Refractory Thyroid Cancers With the BRAF Inhibitor Vemurafenib: A Pilot Study","status":"COMPLETED","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2014-05-20","conditions":["Thyroid Carcinoma"],"enrollment":12,"completionDate":"2024-11-21"},{"nctId":"NCT06993727","phase":"NA","title":"Autoimmune Endocrine Disease Related Antibodies Before the Start of Immune Checkpoint Inhibitor Therapy","status":"RECRUITING","sponsor":"Laura ICONARU","startDate":"2023-11-14","conditions":["Autoimmunity"],"enrollment":500,"completionDate":"2027-12"},{"nctId":"NCT06726967","phase":"","title":"Vitamin D, Hashimato's Thyroiditis and Thyroid Functions","status":"COMPLETED","sponsor":"Ankara Yildirim Beyazıt University","startDate":"2019-02-01","conditions":["Vitamin D","Thyroid Autoimmune Disease"],"enrollment":81180,"completionDate":"2024-01-01"},{"nctId":"NCT03794375","phase":"NA","title":"Primary Care Transfer for Thyroid Cancer Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"Hospital de Clinicas de Porto Alegre","startDate":"2019-01-01","conditions":["Differentiated Thyroid Cancer"],"enrollment":206,"completionDate":"2026-12-31"},{"nctId":"NCT04948437","phase":"","title":"Urinary Exosomal Biomarkers of Thyroglobulin and Galectin-3 for Prognosis and Follow-up in Patients of Thyroid Cancer","status":"RECRUITING","sponsor":"National Taiwan University Hospital","startDate":"2021-08-19","conditions":["Thyroid Cancer","Papillary Thyroid Cancer","Follicular Thyroid Cancer"],"enrollment":103,"completionDate":"2026-10-31"},{"nctId":"NCT05078853","phase":"","title":"Thyroglobulin Point of Care Assay for Rapid Detection of Metastatic Differentiated Thyroid Carcinoma","status":"RECRUITING","sponsor":"Soroka University Medical Center","startDate":"2021-10-06","conditions":["Differentiated Thyroid Cancer","Lymph Node Metastases"],"enrollment":250,"completionDate":"2024-12-31"},{"nctId":"NCT03488134","phase":"","title":"Predicting Prognosis and Recurrence of Thyroid Cancer Via New Biomarkers, Urinary Exosomal Thyroglobulin and Galectin-3","status":"COMPLETED","sponsor":"National Taiwan University Hospital","startDate":"2018-08-03","conditions":["Thyroid Cancer"],"enrollment":74,"completionDate":"2024-02-20"},{"nctId":"NCT06157632","phase":"NA","title":"Role of Preoperative Serum Thyroglobulin Level to Differentiate Between Different Thyroid Nodules","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2023-12-20","conditions":["Level of Thyrogobulin in Different Thyroid Nodules"],"enrollment":30,"completionDate":"2024-11-25"},{"nctId":"NCT04005456","phase":"NA","title":"Personalized Lifestyle Intervention for Improving Functional Health Outcomes Using N-of-1 Tent-Umbrella-Bucket Design","status":"COMPLETED","sponsor":"Metagenics, Inc.","startDate":"2018-09-01","conditions":["Health, Subjective","Gastrointestinal Dysfunction","Cardiovascular Risk Factor","Autoimmune Diseases","Dental Diseases","Hormone Disturbance","Neurocognitive Dysfunction"],"enrollment":400,"completionDate":"2022-12-31"},{"nctId":"NCT06082180","phase":"PHASE3","title":"A Prospective, Open-label, Multicenter, Randomized Controlled Phase III Study of Prophylactic Central Neck Dissection in Low-risk Papillary Thyroid Cancer","status":"RECRUITING","sponsor":"Cancer Institute and Hospital, Chinese Academy of Medical Sciences","startDate":"2022-07-01","conditions":["Thyroid Cancer","Recurrence"],"enrollment":1199,"completionDate":"2026-12-31"},{"nctId":"NCT02347683","phase":"","title":"Optimal Measurement of Thyroglobulin Measurement Following Thyroidectomy","status":"COMPLETED","sponsor":"University of Nebraska","startDate":"2015-01-01","conditions":["Thyroid Cancer"],"enrollment":50,"completionDate":"2016-02-01"},{"nctId":"NCT02774291","phase":"EARLY_PHASE1","title":"Anti-NY ESO-1 mTCR Peripheral Blood Lymphocytes","status":"TERMINATED","sponsor":"Albert Einstein College of Medicine","startDate":"2017-04-20","conditions":["HLA-A2 Positive Cells Present","Metastatic Malignant Neoplasm","Metastatic Malignant Neoplasm in the Brain"],"enrollment":3,"completionDate":"2020-08-04"},{"nctId":"NCT05446012","phase":"","title":"Relationship Between Ectopic Pregnancy and Thyroid Disorders","status":"COMPLETED","sponsor":"Siirt University","startDate":"2022-06-25","conditions":["Ectopic Pregnancy","Thyroid Diseases","Pregnancy, Ectopic"],"enrollment":62,"completionDate":"2022-12-05"},{"nctId":"NCT02408887","phase":"PHASE2","title":"Total Thyroidectomy With and Without Prophylactic Central Neck Lymph Node Dissection in People With Low-risk Papillary Thyroid Cancer","status":"TERMINATED","sponsor":"National Cancer Institute (NCI)","startDate":"2015-04-15","conditions":["Low-risk Papillary Thyroid Cancer","Endocrine Malignancy","Thyroid Cancer"],"enrollment":14,"completionDate":"2019-05-07"},{"nctId":"NCT05542368","phase":"","title":"Study of Thyroid Status in Patients With IBD","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2022-12","conditions":["Thyroid Disease","Irritable Bowel Disease"],"enrollment":90,"completionDate":"2024-12"},{"nctId":"NCT03065218","phase":"PHASE4","title":"99mTc Sestamibi Scans In Thyroglobulin Positive Scan Negative Differentiated Thyroid Cancer (DTC) Patients","status":"TERMINATED","sponsor":"Medstar Health Research Institute","startDate":"2016-10","conditions":["Thyroid Cancer"],"enrollment":4,"completionDate":"2021-02-15"},{"nctId":"NCT02824016","phase":"NA","title":"Evaluation of Hypothyroidism Incidence After Breast Cancer Supraclavicular Irradiation","status":"COMPLETED","sponsor":"Institut Jean-Godinot","startDate":"2013-02","conditions":["Irradiation; Adverse Effect","Irradiation Hypothyroidism"],"enrollment":500,"completionDate":"2020-07"},{"nctId":"NCT03630120","phase":"PHASE2","title":"Adaptive Tyrosine Kinase Inhibitor (TKI) Therapy In Patients With Thyroid Cancer","status":"TERMINATED","sponsor":"H. Lee Moffitt Cancer Center and Research Institute","startDate":"2018-08-06","conditions":["Thyroid Cancer","Thyroid Cancer, Medullary","Differentiated Thyroid Cancer","Papillary Thyroid Cancer","Follicular Thyroid Cancer","Poorly Differentiated Thyroid Gland Carcinoma"],"enrollment":6,"completionDate":"2019-12-05"},{"nctId":"NCT04659200","phase":"","title":"Thyroid Function Tests and Status of Thyroid Autoantibodies in Covid-19 Patients","status":"COMPLETED","sponsor":"Bezmialem Vakif University","startDate":"2020-09-01","conditions":["COVID-19 Infection","Thyroid Function Tests","Inflammation; Thyroid","Inflammatory Markers"],"enrollment":20,"completionDate":"2020-12-07"},{"nctId":"NCT01704586","phase":"NA","title":"I-124 PET/CT Based Remnant Radioiodine Ablation Decision Concept in Differentiated Thyroid Cancer","status":"UNKNOWN","sponsor":"University of Wuerzburg","startDate":"2015-05","conditions":["Differentiated Thyroid Carcinoma"],"enrollment":340,"completionDate":"2025-11"},{"nctId":"NCT02815501","phase":"","title":"Thyroid Dysfunction and Obstetric Complications","status":"WITHDRAWN","sponsor":"Centre Hospitalier Universitaire, Amiens","startDate":"2012-03-01","conditions":["Pregnancy"],"enrollment":0,"completionDate":"2017-10-26"},{"nctId":"NCT03176706","phase":"","title":"Assessment of Dried Blood Spot Thyroglobulin and Urinary Iodine Concentration in Pregnant Women","status":"COMPLETED","sponsor":"Swiss Federal Institute of Technology","startDate":"2017-08-09","conditions":["Iodine Deficiency","Pregnancy Related"],"enrollment":2900,"completionDate":"2019-08-31"},{"nctId":"NCT00625846","phase":"PHASE2","title":"Pazopanib Hydrochloride in Treating Patients With Advanced Thyroid Cancer","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2008-02-22","conditions":["Recurrent Thyroid Gland Carcinoma","Stage III Differentiated Thyroid Gland Carcinoma AJCC v7","Stage III Thyroid Gland Medullary Carcinoma AJCC v7","Stage IVA Differentiated Thyroid Gland Carcinoma AJCC v7","Stage IVA Thyroid Gland Anaplastic Carcinoma AJCC v7","Stage IVA Thyroid Gland Medullary Carcinoma AJCC v7","Stage IVB Differentiated Thyroid Gland Carcinoma AJCC v7","Stage IVB Thyroid Gland Anaplastic Carcinoma AJCC v7","Stage IVB Thyroid Gland Medullary Carcinoma AJCC v7","Stage IVC Differentiated Thyroid Gland Carcinoma AJCC v7","Stage IVC Thyroid Gland Anaplastic Carcinoma AJCC v7","Stage IVC Thyroid Gland Medullary Carcinoma AJCC v7","Thyroid Gland Anaplastic Carcinoma"],"enrollment":152,"completionDate":"2019-08-13"},{"nctId":"NCT02390739","phase":"PHASE1,PHASE2","title":"Administering Peripheral Blood Lymphocytes Transduced With a Murine T-Cell Receptor Recognizing Human Thyroglobulin to People With Thyroglobulin Expressing Thyroid Cancer","status":"WITHDRAWN","sponsor":"National Cancer Institute (NCI)","startDate":"2015-03-02","conditions":["Metastatic Thyroid Cancer"],"enrollment":0,"completionDate":"2017-03-22"},{"nctId":"NCT04141306","phase":"","title":"Radioiodine-avid Bone Metastases From Thyroid Cancer Without Structural Abnormality","status":"UNKNOWN","sponsor":"Hospices Civils de Lyon","startDate":"2019-11","conditions":["Bone Metastases","Thyroid Cancer"],"enrollment":30,"completionDate":"2019-12"},{"nctId":"NCT04128631","phase":"","title":"Thyroid Cancer and (FDG)PET/CT Scan","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2019-10-30","conditions":["Thyroid Cancer"],"enrollment":35,"completionDate":"2020-12-01"},{"nctId":"NCT02329379","phase":"PHASE4","title":"The Role of Levothyroxine on Goiter With Atypia of Undetermined Significance","status":"WITHDRAWN","sponsor":"Sheng-Chiang Su","startDate":"2015-05","conditions":["Goiter"],"enrollment":0,"completionDate":"2015-12-31"},{"nctId":"NCT04019509","phase":"NA","title":"The Influence of Different Thyroid Autoantibodies on Thyroid Function and Pregnancy Outcome After Assisted Reproductive Technology","status":"UNKNOWN","sponsor":"Universitair Ziekenhuis Brussel","startDate":"2019-01-01","conditions":["Fertility Disorders","Thyroid Dysfunction"],"enrollment":900,"completionDate":"2022-09-01"},{"nctId":"NCT00181168","phase":"PHASE2","title":"Recombinant Thyrotropin PET-CT Fusion Scanning in Thyroid Cancer","status":"COMPLETED","sponsor":"Johns Hopkins University","startDate":"2001-03","conditions":["Thyroid Cancer"],"enrollment":63,"completionDate":"2003-09"},{"nctId":"NCT01182285","phase":"PHASE2","title":"A Phase II Trial of Valproic Acid in Patients With Advanced Thyroid Cancers of Follicular Cell Origin","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2010-09-24","conditions":["Thyroid Neoplasm"],"enrollment":13,"completionDate":"2016-04-28"},{"nctId":"NCT03469544","phase":"","title":"Long Non Coding RNA HOTAIR and Midkine as Biomarkers in Thyroid Cancer","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2018-03-29","conditions":["Thyroid Cancer"],"enrollment":90,"completionDate":"2020-03-29"},{"nctId":"NCT00115895","phase":"PHASE3","title":"The Dose of Radioactive Iodine Needed to Ablate the Thyroid Remnant Left Behind After Thyroidectomy","status":"UNKNOWN","sponsor":"University of Helsinki","startDate":"2000-01","conditions":["Thyroid Neoplasms"],"enrollment":160,"completionDate":"2020-09"},{"nctId":"NCT03324334","phase":"","title":"Prevalence of Graves Disease in Patients With Ulcerative Colitis","status":"UNKNOWN","sponsor":"Assiut University","startDate":"2017-11-01","conditions":["Ulcerative Colitis"],"enrollment":95,"completionDate":"2019-02-28"},{"nctId":"NCT00729157","phase":"PHASE2","title":"Aflibercept in Treating Patients With Recurrent and/or Metastatic Thyroid Cancer That Did Not Respond to Radioactive Iodine Therapy","status":"COMPLETED","sponsor":"National Cancer Institute (NCI)","startDate":"2008-08","conditions":["Recurrent Thyroid Gland Carcinoma","Stage III Thyroid Gland Follicular Carcinoma","Stage III Thyroid Gland Papillary Carcinoma","Stage IV Thyroid Gland Follicular Carcinoma","Stage IV Thyroid Gland Papillary Carcinoma"],"enrollment":41,"completionDate":"2012-11"},{"nctId":"NCT02927119","phase":"","title":"Serum Thyroglobulin as a Marker of Iodine Status During Pregnancy","status":"COMPLETED","sponsor":"University of Debrecen","startDate":"2014-08","conditions":["Dietary Iodine Deficiency","Thyroid; Functional Disturbance"],"enrollment":189,"completionDate":"2014-12"},{"nctId":"NCT01931293","phase":"NA","title":"HLA-DRB1 and HLA-DQB1 Genotyping for Autoantibody-positive and -Negative Patients With Atrophic Glossitis or Burning Mouth Syndrome","status":"UNKNOWN","sponsor":"National Taiwan University Hospital","startDate":"2013-04","conditions":["Atrophic Glossitis, Burning Mouth Syndrome"],"enrollment":750,"completionDate":"2016-07"},{"nctId":"NCT00525135","phase":"PHASE2","title":"Valproic Acid (Depakote ER) in Patients With Advanced Thyroid Cancer","status":"TERMINATED","sponsor":"University of California, San Francisco","startDate":"2007-08","conditions":["Head and Neck Cancer"],"enrollment":5,"completionDate":"2009-03"},{"nctId":"NCT02318160","phase":"","title":"Oxidative Status in Children With Autoimmune Thyroiditis","status":"COMPLETED","sponsor":"Assiut University","startDate":"2014-01","conditions":["Autoimmune Thyroiditis"],"enrollment":64,"completionDate":"2014-03"},{"nctId":"NCT01374659","phase":"","title":"Diagnostic Utility of [18F]-FDG-PET/CT and [124I]-PET/CT for Detection of Recurrence in Differentiated Thyroid Carcinoma","status":"UNKNOWN","sponsor":"Korean Association of Endocrine Surgeons","startDate":"2009-07","conditions":["Thyroid Cancer","Recurrence"],"enrollment":50,"completionDate":"2012-08"},{"nctId":"NCT01095341","phase":"","title":"Postoperative Hyperthyroidism","status":"COMPLETED","sponsor":"Heidelberg University","startDate":"2008-04","conditions":["Hyperthyroidism"],"enrollment":57,"completionDate":"2009-04"},{"nctId":"NCT00493103","phase":"","title":"TG Gene Mutations and Congenital Hypothyroidism","status":"COMPLETED","sponsor":"University of Sao Paulo","startDate":"2003-07","conditions":["Congenital Hypothyroidism"],"enrollment":0,"completionDate":"2007-06"},{"nctId":"NCT00439127","phase":"","title":"OnT4-Thyroglobulin Assay Before rhTSH-Aided Radioiodine Ablation","status":"COMPLETED","sponsor":"Oncology Institute of Southern Switzerland","startDate":"2005-01","conditions":["Differentiated Thyroid Carcinoma"],"enrollment":28,"completionDate":"2007-01"},{"nctId":"NCT00148213","phase":"","title":"Clinical Evaluation of a New Highly Sensitive Thyroglobulin Assay in Differentiated Thyroid Carcinoma","status":"COMPLETED","sponsor":"University Hospital Muenster","startDate":"2003-09","conditions":["Thyroid Neoplasms"],"enrollment":100,"completionDate":"2005-06"}],"genericFilers":[],"latestUpdates":[],"manufacturing":[],"crossReferences":{"chemblId":"CHEMBL1201650"},"formularyStatus":[],"_enricherVersion":"v2-openfda","developmentCodes":[],"ownershipHistory":[],"publicationCount":14038,"therapeuticAreas":["Metabolic"],"biosimilarFilings":[],"recentPublications":[],"companionDiagnostics":[],"genericManufacturerList":[],"status":"approved","brandName":"THYROGLOBULIN","companyName":"","companyId":"","modality":"Small Molecule","firstApprovalDate":"1982","aiSummary":"","enrichmentLevel":3,"visitCount":1,"regulatoryByCountry":[{"country_code":"CA","regulator":"Health Canada","status":"approved","approval_date":null,"mah":"","brand_name_local":"","application_number":""},{"country_code":"US","regulator":"FDA","status":"approved","approval_date":null,"mah":null,"brand_name_local":null,"application_number":null}],"trialStats":{"total":0,"withResults":0},"validation":{"fieldsValidated":0,"lastValidatedAt":"2026-04-20T01:56:52.451932+00:00","fieldsConflicting":1,"overallConfidence":0.8},"verificationStatus":"enriching","dataCompleteness":{"mechanism":false,"indications":false,"safety":false,"trials":true,"score":1}}